ProfileGDS4718 / 1552739_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 52% 40% 55% 50% 47% 56% 57% 40% 60% 47% 55% 40% 50% 57% 57% 58% 57% 56% 58% 42% 38% 57% 59% 55% 54% 59% 55% 43% 49% 47% 59% 58% 49% 55% 59% 67% 60% 47% 54% 59% 57% 51% 61% 71% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.6464652
GSM549102patient 115, normal, homogenized [OPG study]5.0010140
GSM549104patient 119, normal, homogenized [OPG study]5.8067255
GSM549108patient 138, normal, homogenized [OPG study]5.558950
GSM549119patient 077, normal, homogenized [OPG study]5.3730947
GSM549133patient 032, cancer, homogenized [OPG study]5.8507856
GSM549139patient 042, cancer, homogenized [OPG study]5.9020657
GSM549099patient 107, normal, homogenized [OPG study]4.999540
GSM549109patient 139, normal, homogenized [OPG study]6.1629160
GSM549110patient 046, normal, homogenized [OPG study]5.3422647
GSM549114patient 063, normal, homogenized [OPG study]5.762455
GSM549122patient 082, normal, homogenized [OPG study]4.9862540
GSM549134patient 033, cancer, homogenized [OPG study]5.5063650
GSM549136patient 036, cancer, homogenized [OPG study]5.9014957
GSM549140patient 044, cancer, homogenized [OPG study]5.8944357
GSM549111patient 047, normal, homogenized [OPG study]6.0013858
GSM549113patient 057, normal, homogenized [OPG study]5.8705757
GSM549132patient 031, cancer, homogenized [OPG study]5.8657156
GSM549137patient 038, cancer, homogenized [OPG study]5.979858
GSM549142patient 047, cancer, homogenized [OPG study]5.2323442
GSM549100patient 110, normal, homogenized [OPG study]4.9008638
GSM549107patient 135, normal, homogenized [OPG study]5.8865357
GSM549115patient 068, normal, homogenized [OPG study]6.006659
GSM549116patient 072, normal, homogenized [OPG study]5.793855
GSM549120patient 078, normal, homogenized [OPG study]5.7182954
GSM549131patient 030, cancer, homogenized [OPG study]6.0140659
GSM549118patient 074, normal, homogenized [OPG study]5.7975355
GSM549129patient 027, cancer, homogenized [OPG study]5.1516843
GSM549123patient 088, normal, homogenized [OPG study]5.4548949
GSM549124patient 006, cancer, homogenized [OPG study]5.3683747
GSM549126patient 015, cancer, homogenized [OPG study]6.0534459
GSM549128patient 025, cancer, homogenized [OPG study]6.0251758
GSM549103patient 117, normal, homogenized [OPG study]5.5208549
GSM549117patient 073, normal, homogenized [OPG study]5.7478455
GSM549138patient 041, cancer, homogenized [OPG study]6.0580559
GSM549141patient 045, cancer, homogenized [OPG study]6.7197867
GSM549130patient 028, cancer, homogenized [OPG study]6.1059260
GSM549101patient 111, normal, homogenized [OPG study]5.4022547
GSM549105patient 128, normal, homogenized [OPG study]5.7537854
GSM549106patient 134, normal, homogenized [OPG study]6.0381359
GSM549112patient 048, normal, homogenized [OPG study]5.9074657
GSM549125patient 011, cancer, homogenized [OPG study]5.5741551
GSM549127patient 024, cancer, homogenized [OPG study]6.2787361
GSM549135patient 035, cancer, homogenized [OPG study]7.0629671